evenfolio

Healthcare · NSE: PARKHOSPS

Park Medi World

Q2 FY27 earnings highlights, from the results presentation

Price as of 16 Nov 2026
245.03−4.13%

Q2 FY27 · From the investor presentation

Read the filing on NSEFiling

1,430​bedsBed additions · FY27Slides · p. 6
5,040​bedsBed capacity · FY27Slides · p. 18
4,440​bedsBed capacity by quarter · Q3 FY27Slides · p. 18
83​%Bed capacity growth · Mar-26 to Dec-28Slides · p. 17
M.Cap
₹10,584Cr
P/E
41.3×
1Y return
—
From 52W high
−19.7%

Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.

Share price

Results Q2 FY27, as filed · consolidated · ₹ Cr

Q2 FY27Year agoYoYQ1 FY27QoQ
Revenue511——476+7.4%
EBITDA102——126-19.3%
EBITDA margin19.9%——26.5%-660 bps
PBTProfit before tax76——105-27.3%
Net profit52——83-36.7%
EPS (₹)1.26——2.05-38.5%

From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.

More figures from the presentation

Company · Capacity
680​bedsBeds added · H1 FY27
“we added 680 beds in just six months through Rudrapur and Panchkula,”
Slidesp. 6
Palam Vihar, Gurugram (Park Platinum) · Capacity
100​bedsBed addition · Q4 FY’27
“3,890 Expansion / +100 (225 → 325) / Q4 FY’27”
Slidesp. 19
Kanpur · Capacity
300​bedsBeds · Q4 FY’27
“Acquisition – O&M / 300 / Q4 FY’27”
Slidesp. 19
Narela, Delhi · Capacity
200​bedsBeds · Q4 FY’27
“Acquisition / 200 / Q4 FY’27”
Slidesp. 19
Zirakpur · Capacity
150​bedsBeds · Dec 2026
“Acquisition / 150 / Dec 2026”
Slidesp. 19
Gorakhpur · Capacity
400​bedsBeds · Apr 2027
“Acquisition - O&M / 400 / Apr 2027”
Slidesp. 19

In short

  1. 01H1 FY27 revenue was INR 9,867 mn, up 22% YoY; Q2 revenue was INR 5,110 mn, up 25%.
  2. 02Q2 EBITDA fell 10% to INR 1,017 mn and net profit fell 31% to INR 545 mn; EBITDA margin was 20% vs 27%.
  3. 03Management said new capacity had a near-term bearing on occupancy and profitability.
  4. 04H1 FY27 margins for the 14 hospitals other than Agra, Panchkula and Rudrapur were 26% EBITDA and 17% net.
  5. 05The company expects 1,430 bed additions in FY27, reaching 5,040 beds by March 2027.
  6. 06Bed capacity is planned to rise c.83% by Dec 2028, to 6,590 beds, funded by internal accruals and debt.
  7. 07Cash was INR 3,713 mn against term debt of INR 1,779 mn.

Capex

Fixed assets INR 10,987 mn at H1 FY27 vs 7,878 mn at FY26

Slides · p. 25
“Reserves 20,728 19,356 Fixed assets 10,987 7,878”

Capacity

Mohali: Mohali expansion +150 beds (350 to 500), Sep 2027

Slides · p. 19
“Expansion / +150 (350 → 500) / Sep 2027”

Ambala: Ambala expansion +200 beds (250 to 450), Oct 2027

Slides · p. 19
“Expansion / +200 (250 → 450) / Oct 2027”

Rohtak: Rohtak greenfield, 250 beds, Jan 2028

Slides · p. 19
“Greenfield / 250 / Jan 2028”

Prayagraj: Prayagraj greenfield on lease, 550 beds, Dec 2028

Slides · p. 19
“Greenfield - Lease / 550 / Dec 2028”

Network of 17 hospitals and 4,290 beds across North India

Slides · p. 9
“17 hospitals and 4,290 beds across North India”

Demand

North India: North India market share expected to grow the fastest

Slides · p. 22
“Market share of North India expected to grow the fastest”

North India: North India bed density below India and global averages, a supply gap

Slides · p. 22
“• North India on average remains below both levels, indicating a significant supply gap”

Growing focus on international patients and premium case mix

Slides · p. 20
“• Growing focus on international patients and premium case mix”

About 10-15% rate increase shown under CGHS rate revision

Slides · p. 23
“~10–15% rate increase Coverage in (Mn)”

About 3 mn beds required in India to bridge demand-supply gap

Slides · p. 22
“~3 Mn beds required”

Margins and costs

Q2 FY27 EBITDA INR 1,017 mn vs 1,127 mn, down 10%; H1 EBITDA up 5% to 2,278 mn

Slides · p. 26
“EBITDA 1,017 1,127 -10% 2,278 2,177 5%”

Q2 FY27 EBITDA margin 20% vs 27%, down 758 bps; H1 margin 23% vs 27%

Slides · p. 26
“EBITDA Margin (%) 20% 27% -758 bps 23% 27% -382 bps”

Q2 cost of material/services up 65% to INR 1,163 mn

Slides · p. 26
“Cost of material consumed /services rendered 1,163 705 65% 1,926 1,405 37%”

14 hospitals other than Agra, Panchkula and Rudrapur: H1 FY27 margins for 14 older hospitals: EBITDA 26%, net profit 17%

Slides · p. 26
“(1) H1 FY’27 EBITDA margin and Net Profit margin for 14 hospitals other than Agra, Panchkula and Rudrapur (additions in the current CY) were 26% and 17%”

Q2 depreciation up 40% to INR 209 mn

Slides · p. 26
“Depreciation 209 149 40% 397 297 34%”

Debt and working capital

Cash of INR 3,713 mn against term debt of INR 1,779 mn

Slides · p. 6
“utilisation and margins. With cash of INR 3,713 mn against term debt of INR 1,779 mn, we have the balance sheet strength”

Fixed deposits of INR 2,950 mn

Slides · p. 20
“• Strong liquidity with ₹2,950 mn in FDs”

Non-current borrowings INR 1,779 mn at H1 FY27 vs 190 mn at FY26

Slides · p. 25
“Non-Current Borrowings 1,779 190 Other Intangible Assets 12 12”

Current borrowings INR 2,792 mn at H1 FY27 vs 2,089 mn at FY26

Slides · p. 25
“Current Borrowings 2,792 2,089 Current Assets”

Trade receivables INR 8,710 mn at H1 FY27 vs 5,935 mn at FY26

Slides · p. 25
“Trade Payables 678 1,090 Trade receivables 8,710 5,935”

Fund raising

Mix of internal accruals and debt to fund scale-up to 6,590 beds

Slides · p. 20
“• Mix of Internal accruals and debt to scale up to 6,590”

Promoter holding at ~82.9%

Slides · p. 20
“• Promoter holding at ~82.9%”

Headroom for equity dilution up to regulatory threshold of ~75%

Slides · p. 20
“• Headroom for dilution up to regulatory threshold (~75%)”

Flexibility for a future equity raise if required

Slides · p. 20
“• Provides flexibility for future equity raise if required”

Headroom to raise debt for future growth

Slides · p. 20
“• Significant headroom to raise debt for future growth”

Acquisitions and new business

Capacity to raise capital for unidentified acquisitions

Slides · p. 20
“• Additional capacity to raise capital for unidentified”

Rudrapur: The Medicity, Rudrapur, 330 beds, operational since Aug 2026

Slides · p. 2
“The Medicity, Rudrapur | 330 beds, Operational since Aug 2026”

Rudrapur: Multi super speciality hospital acquired for Rs 177 Cr (The Medicity, Rudrapur)

Slides · p. 18
“• Multi super speciality for ₹177 Cr; NABH”

Zirakpur: Hospital acquired for about Rs 107 Cr (Mehar Hospital, Zirakpur column)

Slides · p. 18
“• Acquired for ~₹107 Cr • Gurugram cluster to”

Risks

New capacity had a near-term bearing on occupancy and profitability

Slides · p. 6
“As expected, onboarding this new capacity has had a near-term bearing on occupancy and profitability, as new”

Other

H1 FY27 revenue was INR 9,867 mn, up 22% YoY, highest-ever half-year

Slides · p. 6
“delivered our highest-ever half-yearly Revenue of INR 9,867 mn, up 22% YoY, with Q2 Revenue rising”

Q2 FY27 revenue INR 5,110 mn vs 4,102 mn, up 25%; H1 INR 9,867 mn, up 22%

Slides · p. 26
“Revenue (ex Other income) 5,110 4,102 25% 9,867 8,090 22%”

Q2 FY27 net profit INR 545 mn vs 787 mn, down 31%; H1 down 1% to 1,431 mn

Slides · p. 26
“Net Profit 545 787 -31% 1,431 1,442 -1%”

Q2 FY27 EPS INR 1.26 vs 2.05, down 38%; H1 EPS INR 3.31 vs 3.75

Slides · p. 26
“EPS (INR) 1.26 2.05 -38% 3.31 3.75 -12%”

Priorities: integrating new assets, improving utilisation and margins

Slides · p. 6
“capacity and the largest addition in our history. Our priorities now are the seamless integration of these assets, improving”

Sources

Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

Search

Search funds, ETFs, stocks, pages and tools